DOI: https://doi.org/10.14710/dmj.v14i5.50957

HEPATIC NF-kB AND CYR61 SUPPRESSION BY HOLOTHURIA SCABRA METHANOL EXTRACT IN A HIGH-FAT DIET AND DMBA-INDUCED BREAST CANCER MOUSE MODEL

*Demes Chornelia Martantiningtyas orcid  -  Universitas Kristen Maranatha, Indonesia
Raden Ghitas Sariwidyantry  -  Universitas Kristen Maranatha, Indonesia
Open Access Copyright 2025 Demes Chornelia Martantiningtyas, Raden Ghitas Sariwidyantry
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Citation Format:
Abstract

Background: Liver dysfunction is increasingly recognized in the context of breast cancer progression, particularly due to metastasis and systemic inflammation induced by high-fat diet (HFD)1,2 and carcinogens such as 7,12-dimethylbenz[a]anthracene (DMBA). Although some experimental studies have demonstrated the therapeutic potential of sea cucumber extract, its effect on hepatic gene expression in cancer settings remains underexplored.

Objective: This study investigates the modulatory effects of methanol extract of Holothuria scabra on NF-κB and CYR61 gene expression in the liver of a breast cancer mouse model induced by HFD and DMBA.

Methods: A randomized post-test only control group design was employed using C57BL/6J female mice. Animals were divided into five groups including a normal diet group (ND), a positive control group (HFD + DMBA), and three treatment groups receiving sea cucumber methanol extract (SCME) at doses of 0.33, 0.66, and 0.99 g/kg BW. Liver tissues were harvested for analysis of NF-κB and CYR61 mRNA expression via semi-quantitative RT-PCR.

Results: Mice treated with SCME showed dose-dependent reductions in hepatic NF-κB and CYR61 expression. The highest dose (0.99 g/kg BW) significantly downregulated both genes compared to the HFD + DMBA group (p < 0.05).

Conclusion: SCME modulates inflammatory and tumorigenic gene expression in the liver, suggesting potential anti-inflammatory and anticancer activity. Further studies are needed to explore molecular mechanisms and clinical relevance.

Fulltext View|Download

Article Metrics:

Article Info
Section: Original Articles
Language : EN
Recent articles
PROPOSED MECHANISM OF ERLOTINIB-INDUCED RASH FORMATION IN RATS BASED ON THE SKIN EXPRESSION OF CINC1 AND TTP mRNAs HEPATIC NF-kB AND CYR61 SUPPRESSION BY HOLOTHURIA SCABRA METHANOL EXTRACT IN A HIGH-FAT DIET AND DMBA-INDUCED BREAST CANCER MOUSE MODEL DIFFERENTIATING APPENDICITIS TYPES: THE ROLE OF NEUTROPHIL SUBTYPES CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA LEADING TO LIFE-THREATENING HYPOVOLEMIC SHOCK IN CERVICAL CANCER: A CASE REPORT PROGRESSION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO PROLYMPHOCYTIC LEUKEMIA: A RARE CASE REPORT More recent articles
  1. Gan C, Yuan Y, Shen H, et al. Liver diseases: epidemiology, causes, trends and predictions. Signal Transduction and Targeted Therapy 2025;10(1):33. DOI: 10.1038/s41392-024-02072-z
  2. Ma X, Huang T, Chen X, et al. Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics. Signal Transduction and Targeted Therapy 2025;10(1):63. DOI: 10.1038/s41392-024-02104-8
  3. Leser C, Dorffner G, Marhold M, et al. Liver function indicators in patients with breast cancer before and after detection of hepatic metastases-a retrospective study. PLoS One 2023;18(3):e0278454. (In eng). DOI: 10.1371/journal.pone.0278454
  4. Rashid NS, Grible JM, Clevenger CV, Harrell JC. Breast cancer liver metastasis: current and future treatment approaches. Clin Exp Metastasis 2021;38(3):263–277. (In eng). DOI: 10.1007/s10585-021-10080-4
  5. Zou X, Zou H-L, Luo X, et al. Retrospective comparative survival analysis of ablation plus systemic therapy versus systemic therapy alone for breast cancer liver metastases, stratified by extrahepatic metastases status. The Breast 2025;79:103876. DOI: https://doi.org/10.1016/j.breast.2025.103876
  6. Pegram M, Jackisch C, Johnston SRD. Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer. NPJ Breast Cancer 2023;9(1):45. (In eng). DOI: 10.1038/s41523-023-00533-2
  7. Bril F, Elbert A. Metabolic dysfunction-associated steatotic liver disease and urinary system cancers: Mere coincidence or reason for concern? Metabolism 2024;162:156066. DOI: 10.1016/j.metabol.2024.156066
  8. Ye H, Minhajuddin M, Krug A, et al. The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG. Cancer Discov 2021;11(2):500–519. (In eng). DOI: 10.1158/2159-8290.Cd-20-0318
  9. Zhao M, Huang H, He F, Fu X. Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma. Frontiers in Immunology 2023;Volume 14 - 2023 (Review) (In English). DOI: 10.3389/fimmu.2023.1188277
  10. Guo Q, Jin Y, Chen X, et al. NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduction and Targeted Therapy 2024;9(1):53. DOI: 10.1038/s41392-024-01757-9
  11. Yang R, Chen Y, Chen D. Biological functions and role of CCN1/Cyr61 in embryogenesis and tumorigenesis in the female reproductive system (Review). Mol Med Rep 2018;17(1):3–10. DOI: 10.3892/mmr.2017.7880
  12. Huang J, Zhang L, Wan D, et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduction and Targeted Therapy 2021;6(1):153. DOI: 10.1038/s41392-021-00544-0
  13. Roy AM, Iyer R, Chakraborty S. The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability. Cell Reports Medicine 2023;4(9):101170. DOI: https://doi.org/10.1016/j.xcrm.2023.101170
  14. Hossain A, Dave D, Shahidi F. Antioxidant Potential of Sea Cucumbers and Their Beneficial Effects on Human Health. Mar Drugs 2022;20(8) (In eng). DOI: 10.3390/md20080521
  15. Jattujan P, Chalorak P, Siangcham T, et al. Holothuria scabra extracts possess anti-oxidant activity and promote stress resistance and lifespan extension in Caenorhabditis elegans. Experimental Gerontology 2018;110:158–171. DOI: https://doi.org/10.1016/j.exger.2018.06.006
  16. Liliana Wargasetia T, Ratnawati* H, Kinghua Liana L, Larissa L, Valencia Imannuel E. Holothuria scabra Extract Improves Histopathological Features and Inhibits Cancer Growth Through IL-6 and NF-κB Signaling Pathways in Breast Cancer Mice Model. Research Journal of Pharmacognosy 2024;11(2):1–9. DOI: 10.22127/rjp.2023.417833.2233
  17. Banerjee P, Gaddam N, Chandler V, Chakraborty S. Oxidative Stress–Induced Liver Damage and Remodeling of the Liver Vasculature. The American Journal of Pathology 2023;193(10):1400–1414. DOI: https://doi.org/10.1016/j.ajpath.2023.06.002
  18. Zhao H, Wu L, Yan G, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 2021;6(1):263. (In eng). DOI: 10.1038/s41392-021-00658-5
  19. Nejak-Bowen K, Kikuchi A, Monga SP. Beta-catenin-NF-κB interactions in murine hepatocytes: a complex to die for. Hepatology 2013;57(2):763–74. (In eng). DOI: 10.1002/hep.26042
  20. Huang L, Zhao Z, Duan C, et al. Lactobacillus plantarum C88 protects against aflatoxin B1-induced liver injury in mice via inhibition of NF-κB–mediated inflammatory responses and excessive apoptosis. BMC Microbiology 2019;19(1):170. DOI: 10.1186/s12866-019-1525-4
  21. Wargasetia TL, Ratnawati H, Liana LK, Larissa L, Imannuel EV. Holothuria scabra Extract Improves Histopathological Features and Inhibits Cancer Growth Through IL-6 and NF-κB Signaling Pathways in Breast Cancer Mice Model. Research Journal of Pharmacognosy 2024;11(2):1–9. (Article). DOI: 10.22127/RJP.2023.417833.2233
  22. Zhang KW, Wang D, Cai H, et al. IL-6 plays a crucial role in epithelial-mesenchymal transition and pro-metastasis induced by sorafenib in liver cancer. Oncology Reports 2021;45(3) (Article). DOI: 10.3892/or.2021.7926
  23. Zhang C, Wei W, Tu S, et al. Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma. Journal of Biological Chemistry 2024;300(4). DOI: 10.1016/j.jbc.2024.107208
  24. Wargasetia TL. Mechanisms of cancer cell killing by sea cucumber-derived compounds. Investigational New Drugs 2017;35(6):820–826. (Review). DOI: 10.1007/s10637-017-0505-5
  25. Wargasetia TL, Liana LK, Widodo N, Annisa Y, Hermanto FE. Extract of Holothuria scabra exhibits synergistic effect with chemotherapeutic agents against breast cancer in vitro. Journal of Pharmacy and Pharmacognosy Research 2025;13(3):919–924. (Article). DOI: 10.56499/jppres24.2069_13.3.919
  26. Wei Q, Guo JS. Developing natural marine products for treating liver diseases. World J Clin Cases 2022;10(8):2369–2381. (In eng). DOI: 10.12998/wjcc.v10.i8.2369
  27. Tammam MA, Pereira F, Aly O, et al. Investigating the hepatoprotective potentiality of marine-derived steroids as promising inhibitors of liver fibrosis. RSC Adv 2023;13(39):27477–27490. (In eng). DOI: 10.1039/d3ra04843h

Last update:

No citation recorded.

Last update:

No citation recorded.